- Home
- HSCS vs NUWE Comparison
HSCS vs NUWE Comparison
Compare HSCS & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- NUWE
- Stock Information
- Founded
- HSCS 2007
- NUWE 1999
- Country
- HSCS United States
- NUWE United States
- Employees
- HSCS N/A
- NUWE N/A
- Industry
- HSCS Medical Specialities
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HSCS Health Care
- NUWE Health Care
- Exchange
- HSCS Nasdaq
- NUWE Nasdaq
- Market Cap
- HSCS 3.7M
- NUWE 3.9M
- IPO Year
- HSCS 2022
- NUWE N/A
- Fundamental
- Price
- HSCS $3.94
- NUWE $12.12
- Analyst Decision
- HSCS Strong Buy
- NUWE Strong Buy
- Analyst Count
- HSCS 2
- NUWE 1
- Target Price
- HSCS $13.00
- NUWE $714.00
- AVG Volume (30 Days)
- HSCS 187.6K
- NUWE 2.3M
- Earning Date
- HSCS 07-24-2025
- NUWE 08-12-2025
- Dividend Yield
- HSCS N/A
- NUWE N/A
- EPS Growth
- HSCS N/A
- NUWE N/A
- EPS
- HSCS N/A
- NUWE N/A
- Revenue
- HSCS $4,350.00
- NUWE $8,787,000.00
- Revenue This Year
- HSCS $21,003.45
- NUWE $6.53
- Revenue Next Year
- HSCS $533.33
- NUWE $51.63
- P/E Ratio
- HSCS N/A
- NUWE N/A
- Revenue Growth
- HSCS N/A
- NUWE N/A
- 52 Week Low
- HSCS $2.36
- NUWE $6.33
- 52 Week High
- HSCS $6.47
- NUWE $175.98
- Technical
- Relative Strength Index (RSI)
- HSCS 49.70
- NUWE 45.21
- Support Level
- HSCS $3.62
- NUWE $12.81
- Resistance Level
- HSCS $4.14
- NUWE $16.50
- Average True Range (ATR)
- HSCS 0.67
- NUWE 2.02
- MACD
- HSCS -0.05
- NUWE 1.10
- Stochastic Oscillator
- HSCS 12.15
- NUWE 29.51
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.